{"@id":"https://bioecon.ru/technology/oral-integrin-allosteric-modulators/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/oral-integrin-allosteric-modulators/","json":"https://en.bioecon.ru/api/v1/technology/oral-integrin-allosteric-modulators/index.json"},"id":"oral-integrin-allosteric-modulators","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/quantec-ltd/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/shin-etsu-chemical/","https://bioecon.ru/companies/gsk/","https://bioecon.ru/companies/atomwise/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/ph-albio/","https://bioecon.ru/companies/21st-bio/","https://bioecon.ru/companies/cellmeat/","https://bioecon.ru/companies/kilimorgano/"]},"maturity":7,"name":"Oral Integrin Allosteric Modulators","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Allosteric pocket docking"},{"n":2,"title":"Shear-flow leukocyte adhesion assays"},{"n":3,"title":"Oral PK/PD optimization"},{"n":4,"title":"Mucosal healing in IBD"}],"summary":"Orally administered small molecules targeting allosteric regulatory sites on heterodimeric integrins (alpha4beta7, alphavbeta6), locking the receptors in an unbent inactive conformation and blocking pathogenic immune cell extravasation in inflammatory bowel disease and tissue fibrosis.","url":"/technology/oral-integrin-allosteric-modulators/","verified":"2026-11-22"}